Zai Lab , a Shanghai biotech company , recently agreed a deal with Hanmi of South Korea to develop and commercialise a lung cancer drug for the Chinese market .
不久前，总部位于上海的生物科技公司再鼎医药（ZaiLab）宣布与韩国的韩美集团（Hanmi）达成一项协议，将针对中国市场研发一种治疗肺癌药物，并将其商业化。
hanmi